Literature DB >> 9060031

Acute neuropsychiatric findings in a patient receiving fentanyl for cancer pain.

E Bruera1, J Pereira.   

Abstract

A 62-year-old man receiving subcutaneous fentanyl for the management of cancer pain developed generalized central excitation after an overdose of 5000 micrograms of fentanyl. The patient developed acute confusion, restlessness, generalized myoclonus, visual hallucinations, and hyperalgesia and tremors upon tactile stimulation of the arms or legs. These symptoms rapidly disappeared after the administration of 0.2 mg of naloxone. Within an hour the symptoms reappeared and once again, responded immediately after a second injection of 0.2 mg of naloxone. Our findings suggest that fentanyl overdose can occasionally present with general central irritability that responds to naloxone.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9060031     DOI: 10.1016/s0304-3959(96)03238-1

Source DB:  PubMed          Journal:  Pain        ISSN: 0304-3959            Impact factor:   6.961


  5 in total

Review 1.  Drug-induced myoclonus: frequency, mechanisms and management.

Authors:  Félix Javier Jiménez-Jiménez; Inmaculada Puertas; María de Toledo-Heras
Journal:  CNS Drugs       Date:  2004       Impact factor: 5.749

2.  Visual hallucinations on eye closure after orthopedic surgery under general anesthesia.

Authors:  Sumi Otomo; Michiko Sugita; Toshiyuki Yano
Journal:  J Anesth       Date:  2008-11-15       Impact factor: 2.078

3.  [High-dose buprenorphine for outpatient palliative pain therapy].

Authors:  K Gastmeier; E Freye
Journal:  Schmerz       Date:  2009-04       Impact factor: 1.107

4.  Acute Opioid-Induced Myoclonic Reaction after Use of Fentanyl as an Anesthetic Drug for an Emergency Cesarean Section.

Authors:  Dana Khaled Almedallah; Dana Yousef Alshamlan; Erum Mubbashir Shariff
Journal:  Case Rep Neurol       Date:  2018-05-30

Review 5.  The rising crisis of illicit fentanyl use, overdose, and potential therapeutic strategies.

Authors:  Ying Han; Wei Yan; Yongbo Zheng; Muhammad Zahid Khan; Kai Yuan; Lin Lu
Journal:  Transl Psychiatry       Date:  2019-11-11       Impact factor: 6.222

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.